Zonisamide Capsule
Product Images NDC 68001-243

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zonisamide (NDC 68001-243). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Formula Of Zonisamide (345efcc4 6a36 4ddf 8b6c 9c6c844dab0a 01)

Chemical Formula Of Zonisamide (345efcc4 6a36 4ddf 8b6c 9c6c844dab0a 01)
FDA Label Image

Figure 1: Proportion Of Patients Achieving Differing Levels Of Seizure Reduction In Zonisamide And Placebo Groups In Studies 2 And 3 (345efcc4 6a36 4ddf 8b6c 9c6c844dab0a 02)

Figure 1: Proportion Of Patients Achieving Differing Levels Of Seizure Reduction In Zonisamide And Placebo Groups In Studies 2 And 3 (345efcc4 6a36 4ddf 8b6c 9c6c844dab0a 02)
FDA Label Image

Zonisamide Capsules 100mg 100 Capsules Rev 03-17 (Zonisamide Capsules 100mg 100 Capsules Rev 0714)

Zonisamide Capsules 100mg 100 Capsules Rev 03-17 (Zonisamide Capsules 100mg 100 Capsules Rev 0714)
This is a drug information label for a pharmaceutical product manufactured by Glenmark Pharmaceuticals Ltd. The medication, containing 100mg of Zonisamide, is produced for BluePoint Laboratories. The label includes instructions for storage, dispensing to patients by a pharmacist, and a contact number for questions. There is also a note for patients to refer to an accompanying medication guide, available online at the Glenmark Pharmaceuticals website.*
FDA Label Image

Zonisamide Capsules 25mg 100 Capsules Rev 03-17 (Zonisamide Capsules 25mg 100 Capsules Rev 0714)

Zonisamide Capsules 25mg 100 Capsules Rev 03-17 (Zonisamide Capsules 25mg 100 Capsules Rev 0714)
This is a medication label for Zonisamide capsules, USP, with a strength of 25 mg manufactured by Glenmark Pharmaceuticals Ltd. for BluePoint Laboratories. It contains instructions for use, storage conditions, and a warning to keep the drug out of the reach of children. The accompanying medication guide is available online. Contact information for further questions is provided.*
FDA Label Image

Zonisamide Capsules 50mg 100 Capsules Rev 03-17 (Zonisamide Capsules 50mg 100 Capsules Rev 0714)

Zonisamide Capsules 50mg 100 Capsules Rev 03-17 (Zonisamide Capsules 50mg 100 Capsules Rev 0714)
This is a description of a medication containing Zonisamide USP in capsule form, with each capsule containing 50mg of the active ingredient. It is only available with a prescription and comes with a Medication Guide for each patient. The ideal storage temperature is between 15°C and 30°C (59°F to 86°F) in a dry place. This medication is manufactured by Glenmark Pharmaceuticals in India and distributed by BluePoint Laboratories. If you need more information, you can contact them at 1 (888) 7217115.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.